0
Article |

Alternate Causes of Pseudotumor Cerebri FREE

CORNELIS VAN DOP, MD, PHD
Am J Dis Child. 1985;139(6):545. doi:10.1001/archpedi.1985.02140080015013.
Text Size: A A A
Published online

Sir.—The recent article by Huseman and Torkelson1 suggests that the association of pseudotumor cerebri with initiation of thyroxine replacement, which has been reported in patients with primary hypothyroidism,2-6 also occurs in patients with hypothalamic (tertiary) hypothyroidism. Two additional points should be considered.

First, patients with panhypopituitarism who are treated with thyroxine alone may experience rapid declines in plasma cortisol concentrations due to increased metabolism of cortisol.7 Since decreases in plasma cortisol concentrations can precipitate development of pseudotumor cerebri,8,9 one must consider this condition as an alternate cause for the pseudotumor cerebri in the first patient.

In addition, the potential contribution of vitamin A to this syndrome is not discussed. Carotenemia10 and an elevated carotene–vitamin A ratio, common in hypothyroid patients, rapidly return to normal following institution of thyroxine replacement therapy.11 As children seem to be more susceptible to increased intracranial pressure with vitamin

REFERENCES

Huseman CA, Torkelson RD:  Pseudotumor cerebri following treatment of hypothalamic and primary hypothyroidism . AJDC 1984;;138:927-931.
Van Wyk JJ, Grumbach MM:  Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: An example of hormonal overlap in pituitary feedback . J Pediatr 1960;; 57:416-435.
Prendes JL, McLean WT Jr:  Pseudotumor cerebri during treatment for hypothyroidism . South Med J 1978;;71:977.
Van Dop C, Conte FA, Koch TK, et al:  Pseudotumor cerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism . N Engl J Med 1983;;308:1076-1080.
McVie R:  Pseudotumor cerebri and thyroid-replacement therapy . N Engl J Med 1983;;309: 731.
Hymes LC, Warshaw BL, Schwartz JF:  Pseudotumor cerebri and thyroid-replacement therapy . N Engl J Med 1983;;309:732.
Hellman L, Bradlow HL, Zumoff B, et al:  The influence of thyroid hormones on hydrocortisone production and metabolism . J Clin Endocrinol Metabol 1961;;21:1231-1247.
Neville BGR, Wilson J:  Benign intracranial hypertension following corticosteroid withdrawal in childhood . Br Med J 1970;;3:554-556.
Walsh FB:  Papilledema associated with increased intracranial pressure in Addison's inease . Arch Ophthalmol 1952;;47:86.
Escamilla RF:  Carotenemia in myxedema explanation of the typical slightly icteric tint . J Clin Endocrinol Metabol 1942;;2:33-35.
Walton KW, Campbell DA, Tonks EL:  The significance of alterations in serum lipids in thyroid dysfunction: I. The relation between serum lipoproteins, carotenoids and vitamin A in hypothyroidism and thyrotoxicosis . Clin Sci 1965;; 29:199-215.
Stimson WH:  Vitamin A intoxication in adults . N Engl J Med 1961;;265:369-373.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Huseman CA, Torkelson RD:  Pseudotumor cerebri following treatment of hypothalamic and primary hypothyroidism . AJDC 1984;;138:927-931.
Van Wyk JJ, Grumbach MM:  Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: An example of hormonal overlap in pituitary feedback . J Pediatr 1960;; 57:416-435.
Prendes JL, McLean WT Jr:  Pseudotumor cerebri during treatment for hypothyroidism . South Med J 1978;;71:977.
Van Dop C, Conte FA, Koch TK, et al:  Pseudotumor cerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism . N Engl J Med 1983;;308:1076-1080.
McVie R:  Pseudotumor cerebri and thyroid-replacement therapy . N Engl J Med 1983;;309: 731.
Hymes LC, Warshaw BL, Schwartz JF:  Pseudotumor cerebri and thyroid-replacement therapy . N Engl J Med 1983;;309:732.
Hellman L, Bradlow HL, Zumoff B, et al:  The influence of thyroid hormones on hydrocortisone production and metabolism . J Clin Endocrinol Metabol 1961;;21:1231-1247.
Neville BGR, Wilson J:  Benign intracranial hypertension following corticosteroid withdrawal in childhood . Br Med J 1970;;3:554-556.
Walsh FB:  Papilledema associated with increased intracranial pressure in Addison's inease . Arch Ophthalmol 1952;;47:86.
Escamilla RF:  Carotenemia in myxedema explanation of the typical slightly icteric tint . J Clin Endocrinol Metabol 1942;;2:33-35.
Walton KW, Campbell DA, Tonks EL:  The significance of alterations in serum lipids in thyroid dysfunction: I. The relation between serum lipoproteins, carotenoids and vitamin A in hypothyroidism and thyrotoxicosis . Clin Sci 1965;; 29:199-215.
Stimson WH:  Vitamin A intoxication in adults . N Engl J Med 1961;;265:369-373.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.